Arena Pharmaceuticals, Inc. announced that in connection with the financing transaction and the formal commencement of Mr. Lind's employment with Longboard Pharmaceuticals, Inc., or Longboard (formerly Arena Neuroscience, Inc.), Mr. Lind's employment with the Company concluded effective as of October 27, 2020. Pursuant to the Separation Agreement, Mr. Lind voluntarily resigned his employment with Arena Pharmaceuticals, Inc., effective October 27, 2020. Such resignation did not affect Mr. Lind's status as the President and Chief Executive Officer of Longboard.